Moderna, Inc. (MRNA) president exercises options and sells 53,336 shares under 10b5-1 plan
Rhea-AI Filing Summary
Moderna President Stephen Hoge reported an option exercise and share sale in company stock on July 15, 2026. He exercised stock options to acquire a total of 53,336 shares of common stock at an exercise price of $19.15 per share, then sold 53,336 shares in open-market transactions at $67.60 per share pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. Following these transactions, he reports 1,483,848 shares held directly, plus indirect interests in 151,933 shares held by a trust for the benefit of his spouse and children and 4,116 shares held by Valhalla, LLC, with beneficial ownership of the trust shares disclaimed except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 53,336 shares ($3,605,514)
Net Sell
7 txns
Insider
Hoge Stephen
Role
President
Sold
53,336 shs ($3.61M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 37,226 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 16,110 | $0.00 | -- |
| Exercise | Common Stock | 37,226 | $19.15 | $713K |
| Exercise | Common Stock | 16,110 | $19.15 | $309K |
| Sale | Common Stock | 53,336 | $67.60 | $3.61M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 1,521,074 shares (Direct);
Common Stock — 4,116 shares (Indirect, By Valhalla, LLC)
Footnotes (1)
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. This option is fully vested and exercisable.
Key Figures
Shares sold: 53,336 shares
Sale price: $67.60 per share
Options exercised (tranche 1): 16,110 shares at $19.15
+4 more
7 metrics
Shares sold
53,336 shares
Common stock sold in open-market transaction on July 15, 2026 at $67.60 per share
Sale price
$67.60 per share
Price for 53,336 shares of Moderna common stock sold on July 15, 2026
Options exercised (tranche 1)
16,110 shares at $19.15
First stock option tranche exercised into common stock on July 15, 2026
Options exercised (tranche 2)
37,226 shares at $19.15
Second stock option tranche exercised into common stock on July 15, 2026
Direct holdings after transactions
1,483,848 shares
Common stock directly held by Stephen Hoge following July 15, 2026 transactions
Family trust holdings
151,933 shares
Shares held by a trust for the benefit of Hoge’s spouse and children
Valhalla, LLC holdings
4,116 shares
Shares of Moderna common stock held indirectly through Valhalla, LLC
Key Terms
Rule 10b5-1 trading plan, Section 16 beneficial ownership, Stock Option (Right to Buy), pecuniary interest
4 terms
Rule 10b5-1 trading plan regulatory
"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Section 16 beneficial ownership regulatory
"The reporting person disclaims Section 16 beneficial ownership of these securities"
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 19.1500"
pecuniary interest financial
"except to the extent of his pecuniary interest therein, if any"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Moderna (MRNA) President Stephen Hoge report on July 15, 2026?
Stephen Hoge reported exercising options to acquire 53,336 Moderna shares at $19.15 per share and selling 53,336 shares at $67.60 per share. The sales were executed under a pre-established Rule 10b5-1 trading plan adopted on November 13, 2025.
What stock options did Stephen Hoge exercise in Moderna (MRNA) on July 15, 2026?
Hoge exercised fully vested stock options covering 16,110 shares and 37,226 shares, for a total of 53,336 shares of Moderna common stock. Both option tranches had an exercise price of $19.15 per share and an expiration date of August 10, 2026.